Marquette Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-47,166
| Closed | -$158K | – | 156 |
|
|
2024
Q4 | $158K | Hold |
47,166
| – | – | 0.03% | 102 |
|
|
2024
Q3 | $158K | Hold |
47,166
| – | – | 0.03% | 111 |
|
|
2024
Q2 | $156K | Hold |
47,166
| – | – | 0.03% | 83 |
|
|
2024
Q1 | $191K | Hold |
47,166
| – | – | 0.03% | 75 |
|
|
2023
Q4 | $144K | Buy |
47,166
+22,301
| +90% | +$68K | 0.03% | 88 |
|
|
2023
Q3 | $74.6K | Hold |
24,865
| – | – | 0.02% | 123 |
|
|
2023
Q2 | $93K | Hold |
24,865
| – | – | 0.02% | 122 |
|
|
2023
Q1 | $83.3K | Buy |
+24,865
| New | +$83.3K | 0.02% | 124 |
|